SCHEMBL29197407

SCHEMBL29197407

C=CCC1(O)CCC(OCc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.52
OPRL1 P41146 2/20 0.52
DPP4 P27487 1/20 0.52
SIGMAR1 Q99720 2/20 0.47
CARM1 Q86X55 2/20 0.41
PRMT6 Q96LA8 2/20 0.41
TMEM97 Q5BJF2 1/20 0.41
PRMT8 Q9NR22 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
BCHE P06276 2/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSK P43235 1/20 0.40
EPHX2 P34913 1/20 0.40
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13345971 0.92 OPRM1 (0.47) OPRM1OPRL1DPP4SIGMAR1CARM1
SCHEMBL14602694 0.92 OPRM1 (0.47) OPRM1OPRL1DPP4SIGMAR1CARM1
SCHEMBL31570422 0.87 BCHE (0.41) OPRM1OPRL1DPP4SIGMAR1CARM1
SCHEMBL14451368 0.80 DPP4 (0.68) OPRM1OPRL1DPP4SIGMAR1CARM1
Hydrochloric Acid SCHEMBL5514632 0.79 DPP4 (0.67) OPRM1OPRL1DPP4SIGMAR1CARM1
SCHEMBL22488577 0.78 OPRM1 (0.61) OPRM1OPRL1DPP4SIGMAR1CARM1
SCHEMBL1794743 0.78 BCHE (0.40) OPRM1OPRL1DPP4SIGMAR1BCHE
SCHEMBL1794744 0.78 BCHE (0.40) OPRM1OPRL1DPP4SIGMAR1BCHE
SCHEMBL1801136 0.78 BCHE (0.40) OPRM1OPRL1DPP4SIGMAR1BCHE
SCHEMBL28922840 0.78 FABP7 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096858-A1 COMPOUNDS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
CN-117940133-A Therapeutic agents for degradation of mutant BRAF C4医药公司 2024-04-26 CN disclosed
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed